Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Breath Tests × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Carcinoma 1

Interventions

Carboplatin 22 Pemetrexed 17 Cisplatin 17 Paclitaxel 14 pembrolizumab 13 Gemcitabine 8 osimertinib 7 durvalumab 6 Docetaxel 6 Nivolumab 5 Erlotinib Hydrochloride 5 130-nm albumin-bound paclitaxel 4 capmatinib 3 brigatinib 3 anlotinib 3 Gefitinib 3 Drug Therapy 3 vosaroxin 2 volociximab 2 sintilimab 2 pralsetinib 2 ensartinib 2 atezolizumab 2 aflibercept 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Oncolytic Virotherapy 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04419207 2022-04-20

Detecting Lung Cancer Based on Exhaled Breath

Peking University People's Hospital

Carcinoma, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡